Life at the Johns Hopkins School of Medicine
In 2021 and 2023, the FDA approved Wegovy (semaglutide) and Zepbound (tirzapatide), respectively, for chronic weight management, along with increased physical activity and a reduced… Read More »New Published Study Maps Risks and Benefits Associated with Glucagon-Like Peptide 1 Receptor Agonist Use
Dengue, a virus endemic to Latin America and Southeast Asia, infects about 400 million people and causes about 25,000 deaths each year by dengue hemorrhagic… Read More »The Dengue Vaccine Controversy Explained
Cellular and gene therapy-related research in the United States is growing at a fast pace, with many products moving forward in clinical development. Applications of… Read More »Advancing the Manufacturing of Human Cell and Gene Therapies
In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir… Read More »Once-Daily Combination Pills Offer More Than Convenience
Earlier this month, the U.S. House of Representatives approved a bill directly impacting the biomedical research community. If approved by the Senate, the 21st Century… Read More »Legislative Bill Prompts Discussion of Cross-Talk in the Scientific Community